02/14/2025
5:20 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:21 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:22 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:22 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:23 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:10 PM | ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
11:20 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
8:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:37 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:39 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:42 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/09/2024
7:35 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:30 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
8:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:13 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:58 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
7:30 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/07/2024
9:44 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:54 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:35 PM | ADC Therapeutics (Filer)
| Form DEF 14A | |
09/23/2024
3:39 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
08/13/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
08/06/2024
3:26 PM | ADC Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/06/2024
9:06 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
6:37 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
7:00 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:40 PM | ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:41 PM | ADC Therapeutics (Issuer)
Hug Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:43 PM | ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:45 PM | ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:29 PM | ADC Therapeutics (Subject)
Azelby Robert (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
8:30 PM | ADC Therapeutics (Subject)
Squarer Ron (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
8:35 PM | ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:37 PM | ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:38 PM | ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | ADC Therapeutics (Subject)
BIZZARI JEAN-PIERRE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
8:28 PM | ADC Therapeutics (Subject)
Sandor Victor (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:44 PM | ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:46 PM | ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:37 PM | ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
06/14/2024
4:40 PM | ADC Therapeutics (Issuer)
Hug Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:23 PM | ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:25 PM | ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:29 PM | ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
2:33 PM | ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2024
11:32 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:06 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | ADC Therapeutics (Subject)
MALLIK AMEET (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
5:51 AM | ADC Therapeutics (Filer)
| Form 424B5 | |
05/06/2024
5:38 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:29 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
8:31 PM | ADC Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SC 13G | |
04/26/2024
3:21 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024
3:16 PM | ADC Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:06 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/13/2024
3:17 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
3:14 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
2:19 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/13/2024
11:25 AM | ADC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
6:39 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
8:15 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
